Chief Financial Officer
As Chief Financial Officer, Matt Walsh is responsible for the development and execution of Organon’s financial strategy. He is focused on driving profitability and shareholder value and ensuring the highest standard of financial integrity for Organon so it can reach its vision of becoming a leading women’s health company.
Over his career, Matt has served in several public companies as the CFO and in related roles. Before joining Organon, Matt was the Executive Vice President and CFO at Allergan plc, a global pharmaceutical company, and Catalent, Inc., a global provider of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. Previously, he held finance and leadership positions at Escala Group and GenTek. Matt has also served in corporate development and other roles in the chemical and banking industries.
Matt is a CFA® Charterholder. Since 2020, he has served on the board of directors of Certara, Inc., a public company provider of software and consulting services to the life sciences industry, and previously was a board member of Multicolor Corporation, a label solutions provider.
Matt received an M.B.A. and Bachelor of Science in chemical engineering from Cornell University.